Description
Over the past four decades, testicular cancer has equaled - and probably surpassed - Hodgkin's disease as the number one cancer in young men between the ages of 15 and 34. Overall, it is still a rare neoplasm; 1 percent of all male cancers are testicular, with an incidence of two per 100,000 in the adult male population. In teenagers and young men, however, the incidence may be as high as one in 10,000, and it may be slowly increasing. The American Cancer Society estimates by 1999, there will be about 7,400 new cases of testicular cancer that will be diagnosed in the United States, and an estimated 300 men will die of testicular cancer.
Men with undescended testicles are at greatest risk for testicular cancer. About 10 percent of all men with testicular cancer have a history of cryptorchidism or an undescended testicle. Men with undescended testicles have 10 to 40 times the risk of developing a malignancy - one tumor per every 2,000 undescended testes.
For unknown reasons, Caucasians are four times more likely than non-Caucasians to have testicular cancer. The vast majority of testicular cancers in young people are seminomatous. If the tumor is found early and treated by surgical removal of the testis, possibly in combination with radiation, the prognosis is excellent. In fact, with the success rates in early-stage seminomas rapidly approaching 100 percent, oncologists now describe testicular cancer as a curable neoplasm.
The most common types of testicular cancer are seminoma and nonseminoma. Seminomas make up about 40 percent of all cases. These are more sensitive to radiation treatment. Nonseminomas are actually a group of cancers. They include choriocarcinoma, embryonal carcinoma, teratoma and yolk sac tumors. Each of these major testicular cancers grow and spread differently and are treated differently.
Ninety-five percent of all primary testicular tumors arise from germinal elements. Nongerminal elements, Sertoli and Leydig cells, account for roughly 5 percent of all primary testicular tumors.
Germinal neoplasms are traditionally divided into seminomas and a variety of other types of germinal neoplasms, known collectively as nonseminomatous germ cell tumors. A number of prognostic classification schemes are in use for metastatic nonseminomatous testicular cancer and primary extragonadal nonseminomatous germ cell cancers treated with chemotherapy.
(Back to Top)
|